SCHEMBL8360558

SCHEMBL8360558

CCn1c(C)c(CC([NH])=O)c2cc(Cl)ccc21

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.50
CNR2 P34972 4/20 0.49
MAPT P10636 3/20 0.47
MEN1 O00255 2/20 0.47
CYP1A2 P05177 2/20 0.47
CYP2C19 P33261 2/20 0.47
KMT2A Q03164 2/20 0.47
TSHR P16473 2/20 0.47
LMNA P02545 2/20 0.47
MAPK1 P28482 2/20 0.47
RGS12 O14924 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C9 P11712 1/20 0.47
PKM P14618 1/20 0.47
NFKB1 P19838 1/20 0.47
GNAI1 P63096 1/20 0.47
PMP22 Q01453 1/20 0.47
HIF1A Q16665 1/20 0.47
PTGER4 P35408 1/20 0.47
PTGES O14684 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8649405 0.88 ALDH1A1 (0.60) ALDH1A1CNR2MAPTMEN1CYP1A2
SCHEMBL8645800 0.84 CNR2 (0.55) ALDH1A1CNR2MAPTMEN1CYP1A2
SCHEMBL27475357 0.79 ALDH1A1 (0.51) ALDH1A1CNR2MAPTMEN1CYP1A2
SCHEMBL8360559 0.74 KDM4E (0.50) ALDH1A1MAPTMEN1CYP1A2CYP2C19
SCHEMBL3001920 0.74 PLA2G2A (0.67) ALDH1A1MAPTMEN1CYP1A2CYP2C19
SCHEMBL27472762 0.74 PTGS2 (0.53) CNR2PLA2G2A
SCHEMBL8648508 0.72 ALDH1A1 (0.46) ALDH1A1CNR2CYP1A2CYP2C19CYP3A4
SCHEMBL1921261 0.72 PTGER4 (0.72) ALDH1A1MAPTMEN1CYP1A2CYP2C19
SCHEMBL2006287 0.71 PLA2G2A (0.66) ALDH1A1MAPTMEN1CYP1A2CYP2C19
SCHEMBL8296288 0.70 PLA2G2A (0.64) ALDH1A1MAPTMEN1CYP1A2CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5877202-A Indole derivatives useful to treat estrogen-related neoplasms and disorders AVENTISUB II INC. 1999-03-02 US disclosed